Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.95
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets
May 17, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Friday Of The Heavy Week
May 14, 2021
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today
Via
Talk Markets
A Down Day
May 12, 2021
The tech wreck continues because inflation will hurt the costly stock sector more than others.
Via
Talk Markets
Heavy Global Erosion
May 11, 2021
It is an everything-down day. Even the news is down because commenters are being careful.
Via
Talk Markets
Gold Up Four Days In A Row
May 10, 2021
The dollar is at a nearly 3 month low.
Via
Talk Markets
Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference
May 10, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Calm Markets Day
May 07, 2021
Despite seriously disappointing April jobless numbers, markets are gaining all the same.
Via
Talk Markets
Understanding Teva Pharmaceutical Indus's Unusual Options Activity
May 06, 2021
Understanding Teva Pharmaceutical Indus's Unusual Options Activity On Thursday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option...
Via
Benzinga
Finns and Danes
May 05, 2021
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.
Via
Talk Markets
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report
May 05, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States
May 04, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021
May 04, 2021
Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,...
Via
Benzinga
Monday Markets Unhinged
May 03, 2021
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan.
Via
Talk Markets
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 03, 2021
Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest...
Via
Benzinga
Teva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting
May 03, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Another Heavy News Day
April 29, 2021
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.
Via
Talk Markets
Teva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States
April 29, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
A Heavy News Day And Crypto
April 28, 2021
Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today.
Via
Talk Markets
Teva Pharmaceutical Industries (TEVA) Q1 2021 Earnings Call Transcript
April 28, 2021
TEVA earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT
April 28, 2021
Teva Pharmaceutical Industries Ltd’s (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers,...
Via
Benzinga
Exposures
COVID-19
What's Behind Teva's Mixed Q1 Results
April 28, 2021
Increased competition for several of its top products continued to affect the drugmaker's performance in Q1.
Via
The Motley Fool
Recap: Teva Pharmaceutical Q1 Earnings
April 28, 2021
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) rose 1.6% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 17.11...
Via
Benzinga
Markets Are Paralyzed Ahead Of Two-Day FOMC Meeting
April 28, 2021
Strong reports from major U.S. companies are pushing indices higher. But the market is showing low volatility as investors took a temporary pause after a proposal from Joe Biden to raise taxes on...
Via
Talk Markets
Teva Earnings Top But Drugmaker's Sales Just Miss Views
April 28, 2021
Teva earnings fell less than expected but sales came in slightly below estimates for the drug giant. Teva stock was little changed.
Via
Investor's Business Daily
Teva Reports First Quarter 2021 Financial Results
April 28, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Earnings Scheduled For April 28, 2021
April 28, 2021
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million. • Melco...
Via
Benzinga
Teva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets and Assessment of Schizophrenia Clinical Outcomes at Upcoming 2021 American Psychiatric Association Annual Meeting
April 27, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
London Cancel
April 26, 2021
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.
Via
Talk Markets
Exposures
COVID-19
This Risk Might Shock Anyone Holding Johnson & Johnson Stock
April 24, 2021
Lawsuits delayed by the pandemic could give shareholders a nasty surprise in the months ahead.
Via
The Motley Fool
Topics
Death
Lawsuit
Exposures
Death
Financial
Legal
Teva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis (ulcerative rectal colitis), in the United States
April 23, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.